Droperidol in the interim management of severe Mania: Case reports and literature review

E. Sherwood Brown, Steven C. Dilsaver, Theron C. Bowers, Alan C. Swann

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

There is little information in the literature concerning the use of droperidol in psychiatry. This article presents three cases in which extremely agitated and treatment-refractory persons with mixed mania derived benefit from droperidol administered orally. Symptomatic improvement, including decreased agitation and intrusiveness, improved sleep, and decreased rates of sleep, was observed with the use of oral droperidol at doses ranging from 10-80 mg daily. The only adverse reaction was a dystomia in one patient. This article also reviews the limited available literature on the use of droperidol in psychiatry. Only eight English language articles describing the use of droperidol for psychosis or agitation were found. Future controlled studies to examine the usefulness of oral dosing of droperidol in mama are suggested.

Original languageEnglish (US)
Pages (from-to)316-318
Number of pages3
JournalClinical Neuropharmacology
Volume21
Issue number5
StatePublished - Sep 1998

Fingerprint

Droperidol
Bipolar Disorder
Psychiatry
Sleep
Psychotic Disorders
Language

Keywords

  • Agitation
  • Depression
  • Droperidol
  • Mania
  • Oral dosing

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Droperidol in the interim management of severe Mania : Case reports and literature review. / Brown, E. Sherwood; Dilsaver, Steven C.; Bowers, Theron C.; Swann, Alan C.

In: Clinical Neuropharmacology, Vol. 21, No. 5, 09.1998, p. 316-318.

Research output: Contribution to journalArticle

Brown, E. Sherwood ; Dilsaver, Steven C. ; Bowers, Theron C. ; Swann, Alan C. / Droperidol in the interim management of severe Mania : Case reports and literature review. In: Clinical Neuropharmacology. 1998 ; Vol. 21, No. 5. pp. 316-318.
@article{7c1e5fc770ee4836b180c0faea6ec280,
title = "Droperidol in the interim management of severe Mania: Case reports and literature review",
abstract = "There is little information in the literature concerning the use of droperidol in psychiatry. This article presents three cases in which extremely agitated and treatment-refractory persons with mixed mania derived benefit from droperidol administered orally. Symptomatic improvement, including decreased agitation and intrusiveness, improved sleep, and decreased rates of sleep, was observed with the use of oral droperidol at doses ranging from 10-80 mg daily. The only adverse reaction was a dystomia in one patient. This article also reviews the limited available literature on the use of droperidol in psychiatry. Only eight English language articles describing the use of droperidol for psychosis or agitation were found. Future controlled studies to examine the usefulness of oral dosing of droperidol in mama are suggested.",
keywords = "Agitation, Depression, Droperidol, Mania, Oral dosing",
author = "Brown, {E. Sherwood} and Dilsaver, {Steven C.} and Bowers, {Theron C.} and Swann, {Alan C.}",
year = "1998",
month = "9",
language = "English (US)",
volume = "21",
pages = "316--318",
journal = "Clinical Neuropharmacology",
issn = "0362-5664",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Droperidol in the interim management of severe Mania

T2 - Case reports and literature review

AU - Brown, E. Sherwood

AU - Dilsaver, Steven C.

AU - Bowers, Theron C.

AU - Swann, Alan C.

PY - 1998/9

Y1 - 1998/9

N2 - There is little information in the literature concerning the use of droperidol in psychiatry. This article presents three cases in which extremely agitated and treatment-refractory persons with mixed mania derived benefit from droperidol administered orally. Symptomatic improvement, including decreased agitation and intrusiveness, improved sleep, and decreased rates of sleep, was observed with the use of oral droperidol at doses ranging from 10-80 mg daily. The only adverse reaction was a dystomia in one patient. This article also reviews the limited available literature on the use of droperidol in psychiatry. Only eight English language articles describing the use of droperidol for psychosis or agitation were found. Future controlled studies to examine the usefulness of oral dosing of droperidol in mama are suggested.

AB - There is little information in the literature concerning the use of droperidol in psychiatry. This article presents three cases in which extremely agitated and treatment-refractory persons with mixed mania derived benefit from droperidol administered orally. Symptomatic improvement, including decreased agitation and intrusiveness, improved sleep, and decreased rates of sleep, was observed with the use of oral droperidol at doses ranging from 10-80 mg daily. The only adverse reaction was a dystomia in one patient. This article also reviews the limited available literature on the use of droperidol in psychiatry. Only eight English language articles describing the use of droperidol for psychosis or agitation were found. Future controlled studies to examine the usefulness of oral dosing of droperidol in mama are suggested.

KW - Agitation

KW - Depression

KW - Droperidol

KW - Mania

KW - Oral dosing

UR - http://www.scopus.com/inward/record.url?scp=0031722466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031722466&partnerID=8YFLogxK

M3 - Article

C2 - 9789713

AN - SCOPUS:0031722466

VL - 21

SP - 316

EP - 318

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

SN - 0362-5664

IS - 5

ER -